Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Clinical trial NCT03765918 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03765918
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2024-07-25
- Enrollment
- 714
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.